ALBUQUERQUE, N.M., May 7 /PRNewswire-FirstCall/ -- Biomoda, Inc. , Albuquerque, New Mexico, (http://www.biomoda.com), maker of patented early lung cancer detection testing and other cancer diagnostic technology, said today that Albert Goodman, Ph.D., a former Senior Scientist who has been involved in key experimentation at Los Alamos National Laboratories and Sandia National Laboratories, has been elected to its Board of Directors.
Dr. Goodman’s research at Los Alamos has included studies on applications in nuclear medicine and related fields. He also directed experimentation involving transmission of neutron beams, devised instrumentation for detecting mechanical impacts and vibration, was instrumental in the development of optical motion detectors, video disk systems, and shutterless motion picture projection systems.
“We are delighted to add to our Board such an agile, scientific mind, a man who holds several technology oriented patents, and who has the experience that will be very important for us,” said John Cousins, President of Biomoda.
“I look forward to assisting Biomoda, which has patented breakthrough medical diagnostic technology, much of which originated at Los Alamos. It is now being applied in the fight against lung cancer and other cancers,” Dr. Goodman said. “Biomoda’s non-invasive test captures cancer at the cellular level at its earliest stages when detection means the best chance for long-term survival and care.”
“The technology is simple, highly accurate, is cost effective and can be administered at an out-patient clinic or physicians’ office. It is based on a patented porphyin molecule that binds to cancerous or pre-cancerous cells extracted from body fluids such as lung sputum, blood or urine. After the compound attaches itself, the cancerous cells glow red under a florescent light, allowing detection under a microscope. Normal cells will not fluoresce,” Dr. Goodman said.
“I believe Biomoda and its tests can and will decrease the horrible mortality rates from lung and other cancers and am delighted to join its Board,” Dr. Goodman concluded.
“Safe Harbor” Statement: This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations and are naturally subject to uncertainty and changes in circumstances. Actual results may vary materially from expectations contained herein. Biomoda is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Biomoda, Inc., Albuquerque John Cousins, President 505-821-0875 Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com
Biomoda, Inc.
CONTACT: John Cousins, President of Biomoda, Inc., +1-505-821-0875; orPaul Knopick of E & E Communications, +1-949-707-5365,pknopick@eandecommunications.com, for Biomoda, Inc.
Web site: http://www.biomoda.com/
